title: [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
abstract: Chronic hepatitis C virus infection may be associated with extrahepatic manifestations. Thyroid disease related to chronic hepatitis C virus infection has been associated with interferon-alpha treatment. We present the case of a 40-year-old woman with chronic hepatitis C virus infection, who developed subacute thyroiditis during treatment with pegylated interferon-alpha plus ribavirin.
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Universitario La Fe, Valencia, España. pabloabellan@comv.es
authors.forename: Pablo
authors.initials: P
authors.lastname: Abellán Galiana
authors.forename: Antonia
authors.initials: A
authors.lastname: Pérez-Lázaro
authors.forename: Victoria
authors.initials: V
authors.lastname: Aguilera Sancho-Tello
authors.forename: Juan Francisco
authors.initials: JF
authors.lastname: Merino Torres
authors.forename: Marina
authors.initials: M
authors.lastname: Berenguer Haym
authors.forename: Francisco
authors.initials: F
authors.lastname: Piñón Sellés
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013967:Thyroiditis, Autoimmune / Q000139:chemically induced; D013968:Thyroiditis, Subacute / Q000139:chemically induced / Q000209:etiology*; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b